
CYIG
Healthcare · Drug Manufacturers - Specialty & Generic · $1.3M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 14, 2019 | Time not confirmed | — | 0.15 | — |
| Nov 13, 2018 | Time not confirmed | — | 0.14 | — |
| Aug 14, 2018 | Time not confirmed | — | 0.15 | — |
| Mar 31, 2018 | Time not confirmed | — | 0.09 | — |
Spring Pharmaceutical Group, Inc., through its subsidiaries, engages in the research, development, manufacture, and sale of Chinese medicines primarily made from ginseng leaves extract in the People's Republic of China. The company offers Huoliyuan capsule, an herbal medicine for the treatment of chronic hepatitis, diabetes, insomnia, memory loss, menopause syndrome, and other maladies; ginkgo herbal tea; and…